Evert de Jonge

17.2k citations

279 papers · 10.7k · h-index 58

Impact in

Critical Care and Intensive Care Medicine top 0.05%
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Intensive Care Unit Cognitive Disorders
Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management

Papers in

Epidemiology 65
- Sepsis Diagnosis and Treatment 57
Pulmonary and Respiratory Medicine 31
- Respiratory Support and Mechanisms 19

Co-authors: Marcel Levi (36 shared papers)Nicolette F. de Keizer (65 shared papers)Ameen Abu–Hanna (35 shared papers)Tom van der Poll (31 shared papers)Marcus J. Schultz (30 shared papers)Lilian Minne (7 shared papers)David J. van Westerloo (14 shared papers)Hendrik J. F. Helmerhorst (14 shared papers)
Journals: Critical Care Medicine (35 papers)Critical Care (21 papers)Intensive Care Medicine (16 papers)Journal of Critical Care (8 papers)International Journal of Gynecological Cancer (6 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Evert de Jonge

273 papers receiving 10.5k citations

Peers

Countries citing papers authored by Evert de Jonge

Since Specialization

Citations

This map shows the geographic impact of Evert de Jonge's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evert de Jonge with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evert de Jonge more than expected).

Fields of papers citing papers by Evert de Jonge

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evert de Jonge. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evert de Jonge. The network helps show where Evert de Jonge may publish in the future.

Co-authors

The 25 scholars most cited alongside Evert de Jonge, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Evert de Jonge Line = papers co-authored together Evert de Jonge links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 279 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Evaluation of SOFA-based models for predicting mortality in the ICU: A systematic review Critical Care ·Lilian Minne, Ameen Abu–Hanna, Evert de Jonge	2008	401
2	Pharmacological strategies to decrease excessive blood loss in cardiac surgery: a meta-analysis of clinically relevant endpoints The Lancet ·Marcel Levi, Manon E. Cromheecke, Evert de Jonge, Martin H. Prins, Bas A.J.M. de Mol, Ernest Briët, Harry R. Büller	1999	378
3	Effects of selective decontamination of digestive tract on mortality and acquisition of resistant bacteria in intensive care: a randomised controlled trial The Lancet ·Evert de Jonge, Marcus J. Schultz, Lodewijk Spanjaard, Patrick M. Bossuyt, Margaretha B. Vroom, Jacob Dankert, Jozef Kesecioğlu	2003	346
4	Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation* Critical Care Medicine ·Kamran Bakhtiari, Joost C. M. Meijers, Evert de Jonge, Marcel Levi	2004	310
5	Association between administered oxygen, arterial partial oxygen pressure and mortality in mechanically ventilated intensive care unit patients Critical Care ·Evert de Jonge, Linda M. Peelen, Peter Keijzers, Hans C. A. Joore, Dylan W. de Lange, Peter HJ van der Voort, Robert J. Bosman, Ruud AL de Waal, R.M.J. Wesselink, Nicolette F. de Keizer	2008	275
6	Predisposing factors for hypoglycemia in the intensive care unit* Critical Care Medicine ·Titia M. Vriesendorp, Susanne van Santen, J. Hans DeVries, Evert de Jonge, Frits R. Rosendaal, Marcus J. Schultz, J. B. L. Hoekstra	2005	219
7	Tissue factor pathway inhibitor dose-dependently inhibits coagulation activation without influencing the fibrinolytic and cytokine response during human endotoxemia Blood ·Evert de Jonge, Pascale E. P. Dekkers, Abla A. Creasey, C. Erik Hack, Susan K. Paulson, Aziz Karim, Jozef Kesecioğlu, Marcel Levi, Sander J. H. van Deventer, Tom van der Poll	2000	209
8	Association Between Arterial Hyperoxia and Outcome in Subsets of Critical Illness Critical Care Medicine ·Hendrik J. F. Helmerhorst, Marie-José Roos-Blom, David J. van Westerloo, Evert de Jonge	2015	191
9	Effects of different plasma substitutes on blood coagulation: A comparative review Critical Care Medicine ·Evert de Jonge, Marcel Levi	2001	190
10	Identification of deteriorating patients on general wards; measurement of vital parameters and potential effectiveness of the Modified Early Warning Score Journal of Critical Care ·Jeroen Ludikhuize, Susanne M. Smorenburg, (unknown), Evert de Jonge	2012	188
11	Disseminated Intravascular Coagulation Thrombosis and Haemostasis ·Evert de Jonge, Tom van der Poll, Hugo Ten Cate, Marcel Levi	1999	180
12	The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation Blood ·Rendrik F. Franco, Evert de Jonge, Pascale E. P. Dekkers, Janneke J. Timmerman, C. Arnold Spek, Sander J. H. van Deventer, Peter van Deursen, Liesbeth van Kerkhoff, Bob van Gemen, Hugo Ten Cate, Tom van der Poll, Pieter H. Reitsma	2000	165
13	Evaluation of short-term consequences of hypoglycemia in an intensive care unit* Critical Care Medicine ·Titia M. Vriesendorp, J. Hans DeVries, Susanne van Santen, Hazra S. Moeniralam, Evert de Jonge, Yvo B.W.E.M. Roos, Marcus J. Schultz, Frits R. Rosendaal, J. B. L. Hoekstra	2006	164
14	Effect of a Low vs Intermediate Tidal Volume Strategy on Ventilator-Free Days in Intensive Care Unit Patients Without ARDS JAMA ·(unknown), Fabienne D. Simonis, Ary Serpa Neto, Jan M. Binnekade, Annemarije Braber, Karina Bruin, Rogier M. Determann, Geert-Jan Goekoop, J Heidt, Janneke Horn, Gerard Innemee, Evert de Jonge, Nicole P. Juffermans, Peter E. Spronk, Lotte Steuten, Pieter R. Tuinman, Rob B. P. de Wilde, Marijn Vriends, Marcelo Gama de Abreu, Paolo Pelosi, Marcus J. Schultz	2018	155
15	Sepsis and Disseminated Intravascular Coagulation Journal of Thrombosis and Thrombolysis ·Marcel Levi, Evert de Jonge, Tom van der Poll	2003	138
16	Clinical and computed tomography characteristics of COVID-19 associated acute pulmonary embolism: A different phenotype of thrombotic disease? Thrombosis Research ·Lisette F. van Dam, Lucia J.M. Kroft, Lea Imeen van der Wal, Suzanne C. Cannegieter, Jeroen Eikenboom, Evert de Jonge, Menno V. Huisman, Frederikus A. Klok	2020	123
17	Factors that predict outcome of intensive care treatment in very elderly patients: a review Critical Care ·(unknown), Ameen Abu–Hanna, Marcel Levi, Evert de Jonge	2005	120
18	Clinicians’ response to hyperoxia in ventilated patients in a Dutch ICU depends on the level of FiO2 Intensive Care Medicine ·Aafke E. de Graaff, Dave A. Dongelmans, Jan Maria Binnekade, Evert de Jonge	2010	120
19	Metrics of Arterial Hyperoxia and Associated Outcomes in Critical Care* Critical Care Medicine ·Hendrik J. F. Helmerhorst, Derk L. Arts, Marcus J. Schultz, Peter H. J. van der Voort, Ameen Abu–Hanna, Evert de Jonge, David J. van Westerloo	2016	119
20	Regulatory Role of Cytokines in Disseminated Intravascular Coagulation Seminars in Thrombosis and Hemostasis ·Tom van der Poll, Evert de Jonge, M Levi	2001	118

About Evert de Jonge

Evert de Jonge is a scholar working on Epidemiology, Pulmonary and Respiratory Medicine, Hematology, Critical Care and Intensive Care Medicine and Surgery, having authored 279 papers that have together received 10.7k indexed citations. Recurring topics across this work include Sepsis Diagnosis and Treatment (57 papers), Blood Coagulation and Thrombosis Mechanisms (27 papers), Respiratory Support and Mechanisms (19 papers), Venous Thromboembolism Diagnosis and Management (16 papers), Nosocomial Infections in ICU (12 papers), Hemophilia Treatment and Research (10 papers), Hyperglycemia and glycemic control in critically ill and hospitalized patients (10 papers) and Emergency and Acute Care Studies (9 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (1.7k citations), Internal Medicine (570 citations), Emergency Medicine (1.0k citations), Hematology (1.0k citations) and Epidemiology (2.7k citations). Evert de Jonge has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Marcel Levi, Nicolette F. de Keizer, Ameen Abu–Hanna, Tom van der Poll, Marcus J. Schultz, Lilian Minne, David J. van Westerloo, Hendrik J. F. Helmerhorst, Niels Peek and Jeroen Ludikhuize. Their work appears in journals such as Critical Care Medicine, Critical Care, Intensive Care Medicine, Journal of Critical Care and International Journal of Gynecological Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Evert de Jonge

Impact in

Papers in i

In The Last Decade

Evert de Jonge

Peers

Countries citing papers authored by Evert de Jonge

Fields of papers citing papers by Evert de Jonge

All Works

About Evert de Jonge

Explore authors with similar magnitude of impact

Papers in